v3.26.1
Available for Sale Securities
9 Months Ended
Mar. 31, 2026
Available for Sale Securities  
Available for Sale Securities

Note 3:  Available for Sale Securities

The amortized cost, gross unrealized gains, gross unrealized losses, ACL, and approximate fair value of securities available for sale consisted of the following:

March 31, 2026

 

 

Gross

 

Gross

 

Allowance

Estimated

 

Amortized

 

Unrealized

 

Unrealized

 

for

 

Fair

(dollars in thousands)

  ​ ​ ​

Cost

  ​ ​ ​

Gains

  ​ ​ ​

Losses

  ​ ​ ​

Credit Losses

  ​ ​ ​

Value

Debt securities:

Obligations of states and political subdivisions

$

25,635

$

21

$

(1,240)

$

$

24,416

Corporate obligations

28,556

136

(268)

28,424

Asset-backed securities

38,827

447

(143)

39,131

Other securities

 

3,199

 

10

 

(44)

 

 

3,165

Total debt securities

96,217

614

(1,695)

95,136

Mortgage-backed securities (MBS) and collateralized mortgage obligations (CMOs):

Residential MBS issued by governmental sponsored enterprises (GSEs)

130,951

1,837

(4,239)

128,549

Commercial MBS issued by GSEs

103,740

419

(4,350)

99,809

CMOs issued by GSEs

119,799

295

(4,473)

115,621

Total MBS and CMOs

 

354,490

 

2,551

 

(13,062)

 

343,979

Total AFS securities

$

450,707

$

3,165

$

(14,757)

$

$

439,115

June 30, 2025

 

 

Gross

 

Gross

Allowance

Estimated

 

Amortized

 

Unrealized

 

Unrealized

 

for

 

Fair

(dollars in thousands)

  ​ ​ ​

Cost

  ​ ​ ​

Gains

  ​ ​ ​

Losses

  ​ ​ ​

Credit Losses

  ​ ​ ​

Value

Debt securities:

Obligations of states and political subdivisions

$

26,030

$

5

$

(1,772)

$

$

24,263

Corporate obligations

31,199

75

(632)

30,642

Asset-backed securities

42,059

567

(145)

42,481

Other securities

4,007

 

10

 

(53)

 

3,964

Total debt securities

103,295

657

(2,602)

101,350

Mortgage-backed securities (MBS) and collateralized mortgage obligations (CMOs):

Residential MBS issued by governmental sponsored enterprises (GSEs)

138,377

1,623

(5,005)

134,995

Commercial MBS issued by GSEs

96,377

446

(4,821)

92,002

CMOs issued by GSEs

137,346

402

(5,251)

132,497

Total MBS and CMOs

 

372,100

 

2,471

 

(15,077)

 

 

359,494

Total AFS securities

$

475,395

$

3,128

$

(17,679)

$

$

460,844

The amortized cost and estimated fair value of available for sale securities, by contractual maturity, are shown below. Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.

March 31, 2026

 

Amortized

 

Estimated

(dollars in thousands)

  ​ ​ ​

Cost

  ​ ​ ​

Fair Value

Within one year

$

7,058

$

7,075

After one year but less than five years

 

24,539

 

24,376

After five years but less than ten years

 

29,657

 

28,616

After ten years

 

34,963

 

35,069

Total investment securities

 

96,217

 

95,136

MBS and CMOs

 

354,490

 

343,979

Total AFS securities

$

450,707

$

439,115

The carrying value of investment and mortgage-backed securities pledged as collateral to secure public deposits amounted to $272.3 million and $294.3 million at March 31, 2026, and June 30, 2025, respectively. The securities pledged consisted of marketable securities, including $164.5 million and $151.6 million of MBS, $87.5 million and $109.8 million of CMOs, $19.3 million and $29.7 million of State and Political Subdivisions Obligations, and $934,000 and $3.3 million of Other Securities at March 31, 2026, and June 30, 2025, respectively.

During the nine-month period ended March 31, 2025, gross gains of $48,000 and no gross losses were recognized from sales of available-for-sale securities.

The following tables show the gross unrealized losses and fair value of the Company’s investments, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for which an ACL has not been recorded at March 31, 2026, and June 30, 2025:

March 31, 2026

 

Less than 12 months

 

12 months or more

 

Total

 

Unrealized

 

Unrealized

 

Unrealized

(dollars in thousands)

  ​ ​ ​

Fair Value

  ​ ​ ​

Losses

  ​ ​ ​

Fair Value

  ​ ​ ​

Losses

  ​ ​ ​

Fair Value

  ​ ​ ​

Losses

Obligations of state and political subdivisions

$

5,033

$

32

$

12,868

$

1,208

$

17,901

$

1,240

Corporate obligations

5,697

39

7,187

229

12,884

268

Asset-backed securities

12,274

28

867

115

13,141

143

Other securities

2,880

44

2,880

44

MBS and CMOs

 

37,460

 

125

 

149,735

 

12,937

 

187,195

 

13,062

Total AFS securities

$

60,464

$

224

$

173,537

$

14,533

$

234,001

$

14,757

June 30, 2025

 

Less than 12 months

 

12 months or more

 

Total

 

Unrealized

 

Unrealized

 

Unrealized

(dollars in thousands)

  ​ ​ ​

Fair Value

  ​ ​ ​

Losses

  ​ ​ ​

Fair Value

  ​ ​ ​

Losses

  ​ ​ ​

Fair Value

  ​ ​ ​

Losses

Obligations of state and political subdivisions

$

4,882

$

84

$

15,807

$

1,688

$

20,689

$

1,772

Corporate obligations

1,936

6

18,194

626

20,130

632

Asset-backed securities

3,281

2

839

143

4,120

145

Other securities

15

3,578

53

3,593

53

MBS and CMOs

 

57,829

 

465

 

158,105

 

14,612

 

215,934

 

15,077

Total AFS securities

$

67,943

$

557

$

196,523

$

17,122

$

264,466

$

17,679

The following information pertaining to unrealized losses and ACL on securities, by security type, is presented as of March 31, 2026.

Obligations of state and political subdivisions. The unrealized losses on the Company’s investments in obligations of state and political subdivisions include 12 individual securities which have been in an unrealized loss position for less than 12 months and 26 individual securities which have been in an unrealized loss position for more than 12 months. The securities are performing and are of high credit quality. The unrealized losses were caused by increases in market interest rates since purchase or acquisition. Because the Company does not intend to sell these securities and it is more likely

than not that the Company will not be required to sell these securities prior to recovery of their amortized cost basis, which may be maturity, the Company has not recorded an ACL on these securities.

Corporate and Other Obligations. The unrealized losses on the Company’s investments in corporate obligations include five securities which have been in an unrealized loss position for less than 12 months and six individual securities which have been in an unrealized loss position for more than 12 months. The securities are performing and are of high credit quality. The unrealized losses were caused by increases in market interest rates since purchase or acquisition. Because the Company does not intend to sell these securities and it is more likely than not that the Company will not be required to sell these securities prior to recovery of their amortized cost basis, which may be maturity, the Company has not recorded an ACL on these securities.

Asset-Backed Securities. The unrealized losses on the Company’s investments in asset-backed securities include three individual securities which have been in an unrealized loss position for less than 12 months and two individual securities which have been in an unrealized loss position for more than 12 months. The securities are performing and are of high credit quality. The unrealized loss was caused by variations in market interest rates since purchase or acquisition. Because the Company does not intend to sell these securities and it is more likely than not that the Company will not be required to sell these securities prior to recovery of their amortized cost basis, which may be maturity, the Company has not recorded an ACL on these securities.

MBS and CMOs. The unrealized losses on the Company’s investments in MBS and CMOs include 15 individual securities which have been in an unrealized loss position for less than 12 months, and 102 individual securities which have been in an unrealized loss position for 12 months or more. The securities are performing and are of high credit quality. The unrealized losses were caused by increases in market interest rates since purchase or acquisition. Because the Company does not intend to sell these securities and it is more likely than not that the Company will not be required to sell these securities prior to recovery of their amortized cost basis, which may be maturity, the Company has not recorded an ACL on these securities.

The Company does not believe that any individual unrealized loss as of March 31, 2026, is the result of a credit loss. However, the Company could be required to recognize an ACL in future periods with respect to its available for sale investment securities portfolio.

Credit Losses Recognized on Investments.  There were no credit losses recognized in income and other losses or recorded in other comprehensive loss for the three- and nine-month periods ended March 31, 2026, and 2025.